Article
Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jun 2010
Harrison Christine J, Hills Robert K, Moorman Anthony V, Grimwade David J, Hann Ian, Webb David K H, Wheatley Keith, de Graaf Siebold S N, van den Berg Eva, Burnett Alan K, Gibson Brenda E S
Abstract excerpt
PURPOSE: Karyotype is an independent indicator of prognosis in acute myeloid leukemia (AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the true prognostic significance of individual chromosomal abnormalities in this age group remains unclear. PATIENTS AND METHODS: This cytogenetic study of 729 childhood patients classified them into 22 subgroups and evaluated their incidence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
